Recent Headlines
Within Pharmaceuticals
expEDIum Introduces Office EHR and InstaPay, Along with Strategic Rebranding
Expanding its healthcare technology offerings, iTech announces expEDIum Office EHR, a robust Electronic Health Records (EHR) solution, alongside the unveiling of expEDIum InstaPay (eIP) for patient online payment convenience. This move signifies iTech's commitment to delivering practical,... - December 17, 2023 - expEDIum
Empowering Data Privacy: GENINVO Offers Anonymization as a Service
GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.
Hexa Global Ventures Unveils TalentEdgeAI: a Revolutionary Solution to Transform Talent Acquisition and Staffing
TalentEdgeAI is revolutionizing the HR tech landscape by offering a unified platform specifically designed for mid-sized employers and staffing firms. It is providing a seamless, AI-driven solution that intelligently analyzes labor market trends, pinpoints ideal candidates, and optimizes the interview process with the power of AI and machine learning. This doesn't streamline recruitment – it redefines it by accelerating the process, improving the experience, and increasing candidate quality. - December 13, 2023 - TalentEdgeAI
Huntington Study Group and Roche Collaborate on GENERATION HD2 Study
The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a collaboration with Roche-Genentech to optimize our collective experiences in Huntington’s disease (HD) clinical research. Together we are... - December 13, 2023 - Huntington Study Group
Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as Promising Solution for Microvascular Obstruction
Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment of Microvascular Obstruction (MVO) through sonoreperfusion. The study, led by Dr. John J. Pacella and his team at the Center for Ultrasound Molecular Imaging and... - December 13, 2023 - Microvascular Therapeutics, Inc.
Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the prestigious H7 Healthcare Accelerator 2023 Cohort, powered by H7 BioCapital. The program is renowned for providing a dynamic platform... - December 13, 2023 - Microvascular Therapeutics, Inc.
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics has announced the launch of a range of new reagents for the analysis of Dapsone in food. - December 13, 2023 - Creative Diagnostics
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing. - December 13, 2023 - Creative Diagnostics
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics has launched a portfolio of Macrophage Migration Inhibitory Factor (MIF) reagents for researchers. - December 13, 2023 - Creative Diagnostics
Booth Unveiling Soon: Creative Biolabs and Ingenious Antibody Products at AET US 2023
Creative Biolabs highlights its participation in the upcoming Antibody Engineering and Therapeutics US 2023 conference, taking place from December 13–16, 2023. The event will be held in San Diego. - December 07, 2023 - Creative Biolabs
QuBind.com Makes Major Strides in T-Cell Immunotherapy with Revolutionary AI Innovation
In just 18 months, the young startup QuBind.com has achieved a remarkable breakthrough in T-cell immunotherapy, developing an advanced AI stack that is set to revolutionize personalized medicine. This significant milestone, reached with predominantly bootstrap funding, support from friends, family, and a strategic investment from a handful general partners in the PE sector, underscores the company's innovative spirit and scientific prowess. - December 05, 2023 - QuBind Technologies Corp
Announcing the Ales for ALS™ Roadtrip Across America
Over the coming months, Ales for ALS™ will be traveling across the country in an RV to connect with brewers and beer drinkers – all in support of ALS research. - December 04, 2023 - ALS Therapy Development Institute
cyberelements Launches an Attractive Program for MSPs
Since its launch at the beginning of the year, cyberelements has met great success in Europe, delivering business performance with cyber trust, with its “ready in 3 minutes” platform. cyberelements solve the c-level executives’ impossible equation of speed to compliance, shortage... - December 04, 2023 - cyberelements
Blockchain in Healthcare Predictions 2024
The leading peer reviewed specialty journal, Blockchain in Healthcare Today Platform Approaches Journal (BHTY), has published its annual Predictions article for 2024. Subject matter experts forecast near term expectations for the healthcare industry. - December 02, 2023 - Blockchain in Healthcare Today
Medical Device Manufacturers Who Want to Understand the Requirements of the Uk’s New MHRA MORE Platform for Submissions of Device Related Incidents
Quality First International encourages all medical device manufacturers who want to understand the requirements of the UK’s new MORE platform for submissions of device related incidents to participate in their new webinar. - December 01, 2023 - Quality First International
Herb Llama Launches Plant-Based, Adaptogenic Superfood Supplements: a Revolution in Modern Holistic Wellness
Herb Llama, an American wellness company, has launched a new range of adaptogenic, plant-based superfood supplements targeting health-conscious adults. The company, driven by the motto "vitamins as nature intended," ensures its plant-based products align with modern holistic wellness. - November 30, 2023 - Herb Llama
Clear Choice Dermatology Expands to Longview, WA, with New Dermatology and Wound Care Clinic
Clear Choice Dermatology expands with a new clinic in Longview, Washington, featuring dermatology services and a Wound Care & Vascular Medicine division. Clear Choice Dermatology aims to deliver top-tier healthcare services to Longview, reaffirming its commitment to comprehensive dermatological, wound care, and vascular medicine solutions. - November 30, 2023 - Clear Choice Dermatology
eBacMap, LLC and Charm Sciences, Inc., Launch Automated API Integration of Charm’s ATP Data in the eBacMap® Environmental Monitoring and Reporting Platform
eBacMap, LLC, a software developer of environmental mapping, tracking and trending for the food manufacturing industry, in collaboration with Charm Sciences, Inc., a leading provider of real-time sanitation monitoring tests and other innovative food safety solutions, is proud to announce the launch... - November 30, 2023 - eBacMap
FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development
FF Biotherapeutics, a pioneering biotech startup at the forefront of immunotherapy and vaccine development, today announced its active pursuit of Angel investment. This critical funding round aims to propel the development of its groundbreaking Synthetic Standardized Convalescent Plasma (SSCP) and... - November 29, 2023 - FF Biotherapeutics
SciCord Informatics Platform R3.0 Boron Release
SciCord is proud to announce a new release of its Cloud-based Laboratory Informatics Platform. - November 22, 2023 - SciCord
Huntington Study Group® Holds 30th Annual Meeting
The Huntington Study Group® (HSG®), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently held its 30th annual meeting, HSG 2023, November 2-4 in Phoenix, AZ. Hundreds of scientists, industry partners, HSG research... - November 21, 2023 - Huntington Study Group
Performance Inspired Nutrition Partners with Delta Common to Sell PI Products Throughout India
This new partnership offers an exciting opportunity for PI to introduce its clean and natural products to millions. - November 17, 2023 - Performance Inspired Nutrition
Announcing the Recipients of the 2024 Wisconsin Titan 100
Titan CEO and headline sponsor Wipfli LLP are pleased to announce Ms. Ayla Annac, CEO/President of InvivoSciences, Inc. as a 2024 Wisconsin Titan 100. The Titan 100 program recognizes Wisconsin’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished... - November 08, 2023 - InvivoSciences
Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg
Novugen Pharma (USA) LLC has launched Midodrine 2.5mg, 5mg and 10mg in the U.S. upon the approval from ANDA by FDA. Novugen’s Midodrine will be manufactured in Malaysia by Novugen Pharma Sdn. Bhd. Midodrine is indicated for the treatment of symptomatic orthostatic hypotension, a condition defined as a sudden drop in blood pressure upon standing from a sitting or supine position. - November 07, 2023 - Novugen
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics has announced the release of its new line of Carbamazepine Test Reagents. - November 04, 2023 - Creative Diagnostics
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics has recently launched a series of new Minimum Inhibitory Concentration (MIC) assay services for researchers. - November 04, 2023 - Creative Diagnostics
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has launched a range of antibodies, antigens and kits against CLDN6 to support researchers worldwide in preclinical and clinical safety/efficacy testing. CLDN6 may be involved in the development and... - November 04, 2023 - Creative Diagnostics
NAPHIA Elects Executive Leadership
The North American Pet Health Insurance Association’s (NAPHIA) Board of Directors recently held its bi-annual election to appoint its executive officers to a two-year term of service. - November 02, 2023 - NAPHIA - North American Pet Health Insurance Association
IC Formulations, Developer of A Better Gummy®, and Incredo LTD Announce an Exclusive Nutraceutical Gummy Partnership
IC Formulations, an innovative formulator and manufacturer of nutritional supplements and the developer of A Better Gummy®, gummy vitamins and Incredo LTD, a food tech company and developer of Incredo® Sugar, an award-winning sugar-based sugar reduction solution, announce an exclusive gummy... - October 29, 2023 - IC Formulations
Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry
Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services. In response to the escalating demand for precision therapies, ADCs have emerged as a promising... - October 29, 2023 - Creative Biolabs
Microvascular Therapeutics Receives $3.98M Award from Department of Defense for Its Cardiovascular Product
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a $3.98M FY22 Technology/Therapeutic Development – Funding Level 2 grant from the Congressionally Directed Medical Research Programs (CDMRP). Emmanuelle Meuillet, Chief... - October 18, 2023 - Microvascular Therapeutics, Inc.
Gameday CBD Announces Multi-Year Sponsorship Deal with World's Top Senior Player (according to DUPR)
Gameday CBD, the leading CBD brand among athletes in the United States, announced an exciting partnership with Altaf Merchant, the world's Top Senior Pickleball player. This dynamic collaboration aims to educate pickleball players at every skill level about the advantages of CBD, tailored... - October 18, 2023 - Gameday CBD
Huntington Study Group® Observational Pilot Study Shows HSG’s myHDstory® Platform Reaches the Unreachable
The Huntington Study Group® (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc. (HSGCR), a world leader in conducting clinical trials for Huntington’s disease (HD), today announces that the pilot observational study on their innovative online direct-to-patient... - October 16, 2023 - Huntington Study Group
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of NALFIA. - October 15, 2023 - Creative Diagnostics
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics has announced the release of its new line of Azaperone Test Reagents. - October 15, 2023 - Creative Diagnostics
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics has recently announced the launch of its new Checkerboard Assay services to support researchers. - October 15, 2023 - Creative Diagnostics
Rosemarie K. Witter (RKW) Foundation, Inc. Commemorates 11th Anniversary with Fashion Extravaganza in Aid of Lupus
Style with a purpose. Join Rosemarie K. Witter (RKW) Foundation, Inc. at the MWW Fashion Extravaganza Lupus Fundraiser on October 15th, 4pm-8pm, at Bayview House, Captain Bills. Let's celebrate fashion, compassion, and the fight against Lupus together. Enjoy discount coupons, exclusive perks, and a promotional bag. - October 13, 2023 - Rosemarie K. Witter Foundation, Inc.
NuvOx Therapeutics Wins Most Fundable Company by Pepperdine Graziadio Business School
NuvOx Therapeutics (“NuvOx”) is delighted to announce that it achieved the Gold Level recognition on the Pepperdine Graziadio Business School's sixth annual Most Fundable Companies® List. NuvOx Therapeutics competed against over 3,000 of early-stage US companies to be named one of 17 companies in total. - October 11, 2023 - NuvOx Therapeutics
knowRX Strengthens Platform to Support Physician Engagement in Clinical Trial Diversity
knowRX, a clinical trial solutions provider, has launched an Investigator/Provider Learning Center on its PIXS™ platform, focusing on "Cultural Considerations in the Conduct of Clinical Trials." This initiative aims to educate physicians, increasing their awareness and understanding of clinical trials. The goal is to bridge gaps in patient access and awareness, particularly among underrepresented populations, aligning with recent FDA guidelines emphasizing diversity in clinical trials. - October 07, 2023 - knowRX, Inc.
Cayman Chemical Introduces a New Tool to Study Protein-Lipid Interactions
Cayman LipiDOT Strips™ are a simple tool for the rapid identification of protein-lipid interactions. Researchers can screen a protein of interest against 22 biologically relevant lipids in one assay in a single day at a lower price compared with existing commercial options. - October 04, 2023 - Cayman Chemical Company
GeneProof Announces Expansion of Its IVDR-Certified PCR Portfolio
GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027. Currently,... - October 03, 2023 - ALPCO
The Havana Syndrome Organization is Building a Team to Establish a Havana Syndrome Center
The Havana Syndrome organization is teaming up with medical specialists, scientists, technology experts and engineers to establish the 1st Havana Syndrome Center Worldwide to treat and rehabilitate victims of Havana Syndrome. The Center will also serve as a research center to find out the root... - September 27, 2023 - Havana Syndrome, Inc.
NuvOx Closed Oversubscribed Convertible Notes
NuvOx Therapeutics (“NuvOx”) announced that it has closed an oversubscribed convertible notes round, raising approximately $7M out of the originally planned $5M. In this raise, NuvOx leverages large angel groups nationwide, and 11 angel groups joined the round. As a result, NuvOx... - September 27, 2023 - NuvOx Therapeutics
Hemanext Inc. Announces Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food and Drug Administration (FDA). - September 21, 2023 - Hemanext
Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment
Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
NanoCellect Biomedical, a leading pioneer in gentle microfluidic cell sorting technologies, is thrilled to announce the addition of Peter Vander Horn, PhD. to their executive team as Senior Vice President of Research & Development. With an illustrious career marked by groundbreaking... - September 19, 2023 - NanoCellect Biomedical
Hemanext Announces Founder Martin Cannon's Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, marks a significant turning point in its history as the company announces the retirement of its founder, Martin Cannon. Simultaneously, the Hemanext Board of Directors has appointed Andrew Dunham, the... - September 18, 2023 - Hemanext
JoyAI Introduces Advanced Generative AI Stack for Salesforce
With a goal to connect businesses with generative AI in meaningful ways, they’re working to reshape how it’s perceived and help customers see past the novelty of it all. - September 14, 2023 - JoyAI Group, Inc.
Revolutionizing Animal Health Branding: Module Animal Health Utilizes Advanced AI for Next-Generation Pipeline Branding in Biotech
Module Animal Health, an innovative agency specializing in animal health branding, is redefining the biotech branding landscape with its sophisticated, cost-efficient pipeline of branding solutions. The agency offers an extensive suite of services, including product name development, brand identity... - September 13, 2023 - Module Animal Health
National Brain Tumor Society to Launch Campaigns Elevating the Necessity of Clinical Trials and Biomarker Testing Access, Guiding More Informed Treatment Decisions
Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care. - September 13, 2023 - National Brain Tumor Society